DevelopMed Launch

On Wednesday the 9th of December at 11am an exciting new Marie Sklodowska-Curie (MSCA) COFUND Programme was officially launched by University College Dublin. The new programme, ‘Developing the Next Generation of Research Leaders in Precision Oncology’ (DevelopMed), is coordinated by Systems Biology Ireland (SBI) and will support 12 prestigious Precision Oncology Fellowships. In a joint event, the DevelopMed launch also marked and celebrated the end of the highly successful TOPMed10 MSCA COFUND Programme coordinated by SBI. TopMed supported nine postdoctoral fellows in personalised medicine research projects, who have now moved on to prestigious positions in academia and industry.

The virtual joint DevelopMed and TopMed10 event was hosted by Systems Biology Ireland, with Prof. Cecily Kelleher, College of Health and Agricultural Sciences opening proceedings and together with Prof. Orla Feely, VP for Research, Innovation and Impact at UCD formally launching the new UCD led DevelopMed Programme. At the event, attendees heard from TopMed10 Fellows Dr. Sarinj Fattah, Dr Caoileann Murphy, Dr Dina Danso – Abeam and Dr Husvinee Sundaramurth on their experiences of being involved in the programme. Fellows also presented on the research that they carried out during their time in TopMed10. Prof. David Brayden, Professor, School of Veterinary Medicine, University College Dublin described his experience of hosting a fellow and the benefits being part of an MSCA COFUND programme.

Supporting the initiative Prof. Orla Feely said: “It is great to see the success that has been delivered from TopMed10 in terms of training outstanding researchers. DevelopMed builds strategically on this previously successful programme and offers a wonderful opportunity for fellows. We can expect to see excellent researchers come through this programme and go on to enormously rewarding careers, delivering important impact in the exciting area of precision oncology.”

With increasing life expectancy it is anticipated that cancer will soon become the leading cause of mortality within the European Union. Despite technological advancements in genomics, imaging, computational modelling and artificial intelligence, the cancer research community is faced with a shortage in skilled scientists and clinicians able to deploy these technologies in the fight against cancer. DevelopMed is a game-changing interdisciplinary training programme focused on developing the future world leaders in precision oncology. The prestigious fellowships will facilitate training through research to fully equip fellows with the skills and intersectoral competencies to enhance their career development prospects. Fellows will also partake in 3-6 month secondments at global research-performing organisations in industry, academic, clinical and charity settings. DevelopMed will also interact closely with Precision Oncology Ireland, a Science Foundation Ireland Strategic Partnership Programme with partners in the industry and charity sectors.

Remarking on the new programme, the DevelopMed Programme Coordinator, Prof. Walter Kolch said: “We are thrilled with the opportunity to train the next generation of leaders in precision oncology research. DevelopMed provides a unique opportunity to develop excellent scientists and clinicians and to inspire in them an entrepreneurial, cross-disciplinary problem-solving mindset for tackling cancer.”

The first application call for the DevelopMed MSCA COFUND programme opens 1 January 2021 with a closing date of 31 March 2021.

Meet the DevelopMed Supervisors for Call 1

The ‘Developing the Next Generation of Research Leaders in Precision Oncology’ (DevelopMed) MSCA COFUND Programme is delighted to announce that we have eight excellent academic supervisors committed to hosting fellows through Call 1 of the programme. The DevelopMed academic supervisors are leading experts in a wide range of research areas related to precision oncology. Many of the committed programme supervisors are also Principal Investigators in Precision Oncology Ireland (POI), a Science Foundation Ireland Strategic Partnership Programme coordinated by Systems Biology Ireland (SBI). With two committed supervisors also having had experience hosting fellows in SBIs previous MSCA COFUND TopMed10, the DevelopMed programme provides a panel of exceptionally strong potential supervisors for interested applicants.

Prospective applicants to the DevelopMed programme must contact the academic supervisor with whom they intend to work with in DevelopMed to express their interest in submitting a DevelopMed fellowship application. The DevelopMed supervisors for Call 1 of the programme are listed below and further information on the supervisors and their research areas is available here.

  • Prof. David Brayden and Prof. Jeremy Simpson, University College Dublin (UCD)
  • Prof. Adrienne Gorman, National University of Ireland Galway (NUIG)
  • Prof. Rory Johnson, University College Dublin (UCD)
  • Prof. Helen Roche, University College Dublin (UCD)
  • Prof. Afshin Samali, National University of Ireland Galway (NUIG)
  • Prof. Eva Szegezdi, National University of Ireland Galway (NUIG)
  • Prof. Mark Tangney, University College Cork (UCC)

To learn more about the DevelopMed programme, the application process and how to apply visit www.ucd.ie/developmed

DevelopMed Call 2 Now Open

Call 2 of the ‘Developing the Next Generation of Research Leaders in Precision Oncology’ (DevelopMed) Marie Sklodowska-Curie COFUND Programme is now officially open and runs until the 30th of November 2021. The Programme offers prestigious Precision Oncology Fellowships to experienced researchers at the early stage of their career.

DevelopMed, which is coordinated by Systems Biology Ireland (SBI) in UCD, entails an EU investment of €1.32 million. DevelopMed is a training programme which will support the development of high calibre research fellows who are at an early stage of their careers. Fellows will be conducting research throughout Ireland in Precision Oncology within the themes of Diagnostics, Therapeutics & Drug Development and the Tumour Microenvironment. Proposals may be in basic or applied research topics broadly classified within the aforementioned precision oncology themes (e.g. computational modelling, nutrition, obesity, machine learning, immunology etc). Institutions hosting fellows include University College Dublin, the National University of Ireland Galway, University College Cork and the RCSI University of Medicine and Health Sciences.

The aim of DevelopMed is to develop the next generation of skilled researchers who will gain hands-on experience developing cross-disciplinary and entrepreneurial skills through individual research projects with a mandatory 3-6 month secondment at an accredited research organisation (academic, industrial, clinical and/or charity sectors) during their fellowship. Information on eligibility criteria for applicants can be found here.

Furthermore, the DevelopMed programme supports gender equality in research and innovation. All DevelopMed academic partners have signed the Athena SWAN Charter, established to encourage and recognise commitment to advancing the careers of women in science, technology, engineering, maths and medicine (STEMM) employment in research.

To learn more about the DevelopMed programme, the application process and how to apply visit www.ucd.ie/developmed

Meet the DevelopMed Supervisors for Call 2

DevelopMed is delighted to announce the excellent academic supervisors committed to hosting fellows through Call 2 of the programme. The DevelopMed academic supervisors are leading experts in a wide range of research areas related to precision oncology.

Prospective applicants to the DevelopMed programme must contact the academic supervisor with whom they intend to work with in DevelopMed to express their interest in submitting a DevelopMed fellowship application. The DevelopMed supervisors for Call 2 of the programme are listed below and further information on the supervisors and their research areas is available here.

  • Prof. Walter Kolch, University College Dublin (UCD)
  • Prof. Jonathan Bond, University College Dublin (UCD)
  • Dr. Róisín Dwyer, National University of Ireland Galway (NUIG)
  • Prof. David Brayden and Prof. Jeremy Simpson, University College Dublin (UCD)
  • Dr. Sharon McKenna, University College Cork (UCC)
  • Assoc. Prof. Cormac McCarthy and Prof. Michael Keane, University College Dublin (UCD)
  • Assistant Prof. Colm Ryan, University College Dublin (UCD)
  • Dr. Eva Szegezdi, National University of Ireland Galway (NUIG)
  • Prof. William Gallagher, University College Dublin (UCD)
  • Prof. Afshin Samali, National University of Ireland Galway (NUIG)

To learn more about the DevelopMed programme, the application process and how to apply visit www.ucd.ie/developmed

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 945425

EU
TOP